Literature DB >> 6722184

Effects of ammonium chloride and chloroquine on endocytic uptake of liposomes by Kupffer cells in vitro.

J Dijkstra, M Van Galen, G L Scherphof.   

Abstract

In this study we investigated the interaction of liposomes with rat Kupffer cells in maintenance culture by using the lysosomotropic amines ammonium chloride and chloroquine as inhibitors of intralysosomal degradation. The liposomes (large unilamellar vesicles) contained either the metabolically inert 3H-labeled inulin or the degradable 125I-labeled bovine serum albumin. In control incubations, the cells released nearly all accumulated protein label and about 30% of the lipid label when they were incubated in the absence of liposomes, after an initial uptake period of 1 h in the presence of liposomes. This release of label was, for the greater part, suppressed in the presence of ammonia or chloroquine. When the inhibitors were present during the initial uptake period, a several-fold increase in the amount of protein label accumulating in the cells and a smaller, but still marked, increase in lipid label accumulation were observed. The effect of ammonia when present during uptake was readily reversible in contrast to that of chloroquine. Experiments with encapsulated inulin revealed that both lysosomotropic agents also affected the uptake process per se to some extent, probably as a result of impaired membrane/receptor recycling. Labeled liposomes adsorbed to the cells at 4 degrees C were effectively internalized and processed intracellulary after shifting the temperature to 37 degrees C, even when a 500-fold excess of unlabeled liposomes was present in the medium during the 37 degrees C incubation. The observed effects of ammonia and chloroquine indicate that, after uptake, the liposomes are degraded within lysosomes, thus confirming our previous conclusion that endocytosis is the major uptake mechanism at 37 degrees C. From the temperature-change experiments we conclude that, at 4 degrees C, the liposomes are bound with high affinity to the cells, remaining firmly attached to the cell-surface structures which initiate their internalization when the temperature is raised to 37 degrees C.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6722184     DOI: 10.1016/0167-4889(84)90099-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Single cell metabolic profiling of tumor mimics.

Authors:  Richard B Keithley; Eric M Weaver; Andrea M Rosado; Mark P Metzinger; Amanda B Hummon; Norman J Dovichi
Journal:  Anal Chem       Date:  2013-09-12       Impact factor: 6.986

2.  Liposomes in chemo- and immunotherapy of cancer.

Authors:  G L Scherphof; T Daemen; H H Spanjer; F H Roerdink
Journal:  Lipids       Date:  1987-11       Impact factor: 1.880

Review 3.  Liposomes in treatment of infectious diseases.

Authors:  F Emmen; G Storm
Journal:  Pharm Weekbl Sci       Date:  1987-06-19

4.  Distinct effects of endosomal escape and inhibition of endosomal trafficking on gene delivery via electrotransfection.

Authors:  Lisa D Cervia; Chun-Chi Chang; Liangli Wang; Fan Yuan
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

5.  Formulation, characterization and tissue distribution of a novel pH-sensitive long-circulating liposome-based theranostic suitable for molecular imaging and drug delivery.

Authors:  Yin Duan; Lihui Wei; Julia Petryk; Terrence D Ruddy
Journal:  Int J Nanomedicine       Date:  2016-11-01

6.  OR14I1 is a receptor for the human cytomegalovirus pentameric complex and defines viral epithelial cell tropism.

Authors:  Xiaofei E; Paul Meraner; Ping Lu; Jill M Perreira; Aaron M Aker; William M McDougall; Ronghua Zhuge; Gary C Chan; Rachel M Gerstein; Patrizia Caposio; Andrew D Yurochko; Abraham L Brass; Timothy F Kowalik
Journal:  Proc Natl Acad Sci U S A       Date:  2019-03-20       Impact factor: 11.205

Review 7.  Drug Delivery with Polymeric Nanocarriers-Cellular Uptake Mechanisms.

Authors:  Levi Collin Nelemans; Leonid Gurevich
Journal:  Materials (Basel)       Date:  2020-01-13       Impact factor: 3.623

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.